Episoder
-
The increasing number of people living with two or more chronic disorders (multimorbidities) poses an urgent need to better understand underlying mechanisms for better prevention and care throughout the life course. Somatic disorders e.g., type 2 diabetes and brain disorders e.g., Alzheimer’s disorder often co-occur. If a single molecule was the key to some of the greatest health challenges of our time, what would tomorrow look like?
The EU-funded PRIME project aims to unravel the insulin-dependent mechanisms underlying both somatic conditions (e.g., type 2 diabetes, obesity, metabolic syndrome) and brain disorders (e.g., Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders).
In this new Brain Talks episode on the integration of mental and somatic health, Sam Pauly sat down with two partners in this EU-funded project PRIME: Silke Matura, Group Leader at the Goethe University Hospital, and Simone Macri, Researcher at the Italian National Institute of Health. -
The Covid-19 pandemic shed a crude light on how instrumental research and innovation are in the European Union. This crisis revealed significant disparities and fractures between Member States. More importantly, patients living with neurological or mental disorders were heavily impacted by the pandemic, and faced tremendous challenges to maintain their access to care and to meet their medical needs.
In this episode, Frederic Destrebecq, Executive Director of the European Brain Council, Christian Suojanen, Founder & CEO of Broadreach Global, and Professor Michel Goldman, renowned medical doctor and researcher, discuss the post-pandemic European landscape, and address the major challenges and opportunities for brain research and innovation in the EU.
From fostering a collaborative climate within the wider brain community to an ambitious European Brain Research and Innovation Plan, join our journey on what it takes to make brain research and innovation a European priority for the 21st century. -
Mangler du episoder?
-
This Brain Talks episode on Urban Environment and Brain Health features two projects on brain health, funded by the European Union under the same main programme (H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being): BRAINTEASER and eMOTIONAL Cities.
Evidence shows that environmental factors may influence both the aetiology and the progression of a number of brain conditions. Through cost-effective sensors and apps, a comprehensive analysis of clinical, lifestyle and environmental data and predictive/preventive AI models for patient stratification and disease progression, BRAINTEASER aims to better inform people living with MS and ALS and support clinical decision making in 4 urban areas: Madrid, Turin, Lisbon and Pavia.
Urban living is associated to an increase in mood and anxiety disorders, drugs addiction and risk of schizophrenia and psychosis. Through urban stress research, emotional mapping, urban prevention and therapy research, eMOTIONAL Cities aims to explore how urban planning and design could positively impact brain health in 4 cities: Lisbon, Copenhagen, London and Lansing. -
Despite the burden, migraine is not consistently recognized in health policy. However, countries are making progress and establishing a way forward for patients.
In the latest Brain Talks episode, Sam Pauly sat down with Dawn Carlson, AbbVie's Vice-President of Neuroscience Clinical Development, and Alessandra Sorrentino, migraine patient and representative of Alleanza Cefalalgici, to discuss promising developments in migraine care, management, and policy prioritization.
This episode was recorded in partnership with AbbVie. -
In this third episode of Brain Talks | Season 3, Alice Medialia (Columbia University), Péter Kéri (GAMIAN-Europe), and John Saunders (EUFAMI) sat down with Sam Pauly to share some thoughts and advices on how to ensure the meaningful engagement of patients with lived experiences of mental health conditions.
In partnership with Boehringer Ingelheim, this episode was recorded live from the third edition of the Brain Innovation Days -
Join us for the second episode of this new season of Brain Talks, where Dimitrios Georgiopoulos, Global Business Franchise Head for Neurology and Immunology at Merck Healthcare, delves into the world of Multiple Sclerosis (MS) care.Discover Merck's patient-centered approach and explore the challenges and opportunities for young people living with MS in the EU. With 2.9 million people affected, this is a conversation that impacts us all.
-
Brain Talks are back for a third season!
Join us in unveiling the highly anticipated 2023 edition of the Brain Innovation Days with Prof. Suzanne Dickson, President of the European Brain Council, and Frédéric Destrebecq, Executive Director of EBC. -
Tune in to the new podcast episode to hear Sam Pauly talk with two expert guests Professor Asgeir Jakola, Director of the European Association of Neurosurgical Societies (EANS) Research Fund & Dr Victor Staartjes, a neurosurgery resident at the University Hospital Zurich. They look at how the EANS Research Fund facilitates neurosurgical research across Europe.
-
In today's Brain Talk, we’ll be looking at the role technology currently plays in neurosurgery. We are joined by Dr Pieter Kubben, a neurosurgeon at Maastricht University Medical Center and the founder of the Neuromind App and Dr. Marike Broekman, a neurosurgeon in the Department of Neurosurgery at Leiden University Medical Center. She is the first female board member of the European Association of Neurosurgical Associations or EANS, and her main clinical and research interests focus on Neuro-Oncology and Ethics.
-
We're back from our summer break and our host, Sam Pauly, is delighted to be joined today by Dr Orla Galvin, Executive Director of the European Federation of Neurological Associations (EFNA) to discuss the important role patients play in guiding policy and leading advocacy in the brain space, particularly as the "experts" in their own brain conditions. A common phrase in the community always is, "nothing about us without us", a strong call to decision-makers to ensure that the people most affected by their decisions are involved from the beginning.
Accompanied by Dr Elke De Witte, Head of Project Development at the European Brain Council, Sam explores the importance of patient involvement in policy and advocacy, the challenges and roadblocks faced to do so (and how to overcome them) and innovative approaches for improvement at present and in the future.
For more information, visit http://efna.net/ and braininnovationdays.eu -
We're taking a short summer break! We leave you with a short interview with the Executive Director of the European Brain Council, Frédéric Destrebecq, led by host Sam Pauly. Sam exchanges with Fred on the history and mission behind the birth of the Brain Innovation Days and what to expect at the 2nd in-person event this coming 11-12 October 2022 in Brussels, Belgium.
Take a look at the programme now: https://www.braininnovationdays.eu/programme-2022/
We hope to welcome you in Brussels later this year - wishing you all a great summer and see you soon. -
Today we turn the spotlight to neuroscience in Africa and discuss with leading researchers from the region how the African neuroscience community has come together to identify challenges and opportunities in the region, explore possible solutions, and discover unique and important avenues for research.
We are delighted to welcome Dr Mahmoud Bukar Maina, Research Fellow in Neuroscience at the University of Sussex and Professor Sadiq Yusaf, Board Member of the International Brain Research Organisation (IBRO) Africa Regional Committee and President of the Society of Neuroscientists of Africa (SONA).
Discover more on:
ibro.org/regions/africa-committee
sonafrica.org
braininnovationdays.eu -
Today our host Sam Pauly speaks with a recent recipient of the Federation of European Neuroscience Societies (FENS) European Journal of Neuroscience (EJN) Young Investigator Prize, awarded to early-career researchers in recognition of their outstanding scientific contributions to any area of neuroscience.
We are delighted to welcome Dr Nicolas Renier — who received the prize for his work in mapping neuronal and vascular networks in transparent brains — group leader at the Paris Brain Institute, studying the development of the brain throughout life using cutting-edge imaging methods.
From the European Journal of Neuroscience, the official journal of FENS, we welcome two senior editors: Dr Paola Bovolenta and Dr Antoine Adamantidis.
Find more on braininnovationdays.eu -
We know that the COVID-19 pandemic has had repercussions far and wide, but what impact has it had on Mental Health Services and what work can be done to address some of those needs? That’s exactly what the Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) has been researching through a focused survey.
The report has just been released and here to tell us more about the findings we have Nigel Olisa, Executive Director of GAMIAN-Europe, and Chiara Samele, Director of Informed Thinking with over 20 years of experience in mental health research.
Discover more on braininnovationdays.eu -
Today we’ll be looking at pioneering work that was recently recognised by the European Paediatric Neurology Society (EPNS) and awarded an EPNS Research Prize.
Beta-propeller protein-associated neurodegeneration, commonly known as BPAN, is a rare, progressive and life-limiting neurological disorder beginning in infancy or early childhood. Dr Apostolos Papandreou, from University College London, is leading research into treatments for the disorder which could also have positive implications on more common disorders as well.
To tell us more, we welcome in this episode also Dr Jean-Pierre Lin, EPNS Board Member and President of the British Paediatric Neurology Association.
Discover more on braininnovationdays.eu -
The new season of Brain Talks focuses on Brain in the Life Course, kicking off with a focus on pediatric neurology. We are joined by guest Dr David Gómez-Andrés, a specialist in Child Neurology at the University Hospital of Vall d’Hebron in Barcelona and part of the European Paediatric Neurology Society (EPNS), a society for physicians with a research or clinical interest in Paediatric Neurology.
Dr Gómez-Andrés was awarded the 2021 EPNS Research Prize by the Neuromuscular Working Group for his work on ‘Pattern Recognition Muscle MRI in Early Onset Muscle Disorders: From Previous Works to Future Plans’.
David reported: ‘My plan is to use the award to continue the project of machine learning and data representation in muscle imaging. Probably, we will join this to other sources for hiring a young child neurologist to help us in this project and other ones we have ongoing.’
We also welcomed Professor Thomas Sejersen, a senior consultant and lecturer at Karolinska University Hospital in Stockholm and a Board Member of the EPNS, as a co-discussant.
Discover more on https://www.epns.info/ and https://www.braininnovationdays.eu -
The second edition of the Brain Innovation Days will take place on 11-12 October 2022.
But you don't have to wait! Follow us during the second season of the Brain Talks where we will invite young researchers to talk about their projects and the future of brain research.
More info on braininnovationdays.eu -
In today's Brain Talk, we are joined by Professor Juan Lerma, Editor-in-Chief of Neuroscience and Professor at the Alicante Neuroscience Insitute. We discuss a number of exciting, current topics within neuroscience, including brain computer interfaces, brain implant devices and the example of the mainstream news of Elon Musk's Neuralink.
Prof Lerma recently wrote a comment on the Neuralink announcement in Neuroscience, the flagship journal of IBRO: https://ibro.org/professor-juan-lerma-reviews-neuralink/?fbclid=IwAR1E-62hfS5Lmq7WNo4dhKZgtkTuhmgp6W-s7PKZYCmNE4gplkl63HGIwO0
To learn more, please visit braininnovationdays.eu -
In today’s Brain Talk we welcome back another speaker from our latest Brain Innovation Days Digital Session on 27 April, “Fast-Tracking Brain Innovation in Times of COVID-19” -- Dr Tomás Ryan, Assistant Professor of Neuroscience at the University at Trinity College Dublin and Chair of the FENS-Kavli Network of Excellence.
During the last event, Tomás provided concluding remarks, sharing the perspective of an early to mid-career fundamental neuroscience researcher, touching on how the scientific community is going to respond to the pandemic in terms of European brain health and brain research and the central issue of harmonization and collaboration in research. COVID-19 brought most fundamental research to a halt last year, which had huge impact at all levels, as everything we are able to do within neurology and psychiatry comes from basic research. Today's podcast elaborates further on these topics of discussion.
Discover more on braininnovationdays.eu -
vCreate Neuro is an NHS Trusted secure video messaging service that helps patients, families and clinical teams stay connected throughout their care journey.
Used in over 150 units globally, the vCreate service has so far helped support more than 20,000 families with separation anxiety, clinical diagnoses and care management.
We discuss the aims and the importance of this platform with Prof Sameer Zuberi, President of the European Paediatric Neurology Society (EPNS) and Clinical Lead of vCreate Neuro.
For more information on vCreate Neuro, visit: https://www.vcreate.tv/neuro
For more information on the Brain Innovation Days, please visit braininnovationdays.eu - Se mer
